U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
136741136741Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of GlaucomaRecruitingNo Results AvailableGlaucoma|Myopiahttps://ClinicalTrials.gov/show/NCT00772993
136742136742Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective TinnitusCompletedNo Results AvailableSubjective TinnitusDrug: Neramexane mesylate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00772980
136743136743A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)CompletedHas ResultsOsteoarthritisDrug: Naproxen|Drug: Placebo|Drug: Ultracethttps://ClinicalTrials.gov/show/NCT00772967
136744136744Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and ImmunogenicityTerminatedHas ResultsClostridium Difficile Infection|Clostridium Difficile DiarrheaBiological: Vaccine diluent buffer|Biological: Clostridium difficile toxoid vaccine (50 μg)|Biological: Clostridium difficile toxoid vaccine (100 μg)https://ClinicalTrials.gov/show/NCT00772954
136745136745Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)CompletedHas ResultsSmoking CessationDrug: Vareniclinehttps://ClinicalTrials.gov/show/NCT00772941
136746136746Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™CompletedHas ResultsDiphtheria|Tetanus|Haemophilus Infection|Pertussis|PolioBiological: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®|Biological: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®https://ClinicalTrials.gov/show/NCT00772928
136747136747Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingHas ResultsMultiple Myeloma and Plasma Cell NeoplasmDrug: dexamethasone|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00772915
136748136748ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation TrialCompletedNo Results AvailableHIV-1Drug: Truvada + Kaletra|Drug: Kivexa + Kaletrahttps://ClinicalTrials.gov/show/NCT00772902
136749136749Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the ElderlyCompletedHas ResultsInfluenza InfectionBiological: Influenza vaccine GSK2186877A|Biological: GSK Biologicals' Fluarixâ„¢https://ClinicalTrials.gov/show/NCT00772889
136750136750A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory MalignanciesCompletedNo Results AvailableCancerDrug: P1446A-05https://ClinicalTrials.gov/show/NCT00772876
136751136751Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian CancerCompletedNo Results AvailableOvarian NeoplasmsDrug: docetaxel and cisplatinhttps://ClinicalTrials.gov/show/NCT00772863
136752136752Rotator Cuff Injury in Antegrade Locked Nailing for Humeral FracturesCompletedNo Results AvailableHumeral Fractureshttps://ClinicalTrials.gov/show/NCT00772850
136753136753Effect of Eradication of Helicobacter Pylori on the Dyspeptic SymptomsCompletedNo Results AvailableFunctional Dyspepsia|Helicobacter Pylori InfectionDrug: Omeprazole + Clarithromycin + Amoxycillin|Drug: Omeprazole + placebo antibioticshttps://ClinicalTrials.gov/show/NCT00772837
136754136754Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer PatientsRecruitingNo Results AvailableBreast CancerDietary Supplement: Glutamine|Dietary Supplement: IV Glutaminehttps://ClinicalTrials.gov/show/NCT00772824
136755136755Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple MyelomaCompletedNo Results AvailableChronic Lymphocytic Leukemia|Lymphoma|Multiple MyelomaDrug: Flu-Melhttps://ClinicalTrials.gov/show/NCT00772811
136756136756A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerRecruitingNo Results AvailableOvarian CancerDrug: Paclitaxel, Carboplatin and Vorinostathttps://ClinicalTrials.gov/show/NCT00772798
136757136757Study of Probuphine in Patients With Opioid DependenceTerminatedNo Results AvailableOpioid DependencyDrug: Probuphine (buprenorphine implant)https://ClinicalTrials.gov/show/NCT00772785
136758136758Vitamin D Repletion in Chronic Kidney DiseaseCompletedHas ResultsChronic Kidney DiseaseDrug: Vitamin D3https://ClinicalTrials.gov/show/NCT00772772
136759136759Assess Safety, Tolerability and PK of AZD3199 in JapaneseCompletedNo Results AvailableHealthyDrug: AZD3199 Turbuhaler®|Drug: Placebo Turbuhaler®https://ClinicalTrials.gov/show/NCT00772759
136760136760Cognitive Behavioral Therapy in Panic DisorderCompletedNo Results AvailablePanic Disorderhttps://ClinicalTrials.gov/show/NCT00772746
136761136761A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) TreatmentCompletedNo Results AvailableCOPD|Chronic Diseaseshttps://ClinicalTrials.gov/show/NCT00772733
136762136762Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy VolunteersRecruitingNo Results AvailableHealthy VolunteersDrug: raltegravir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00772720
136763136763A Multi‐Center Investigation of Patient Acceptability of OPTI‐FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)CompletedHas ResultsMyopiaDevice: Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH)|Device: Contact Lenseshttps://ClinicalTrials.gov/show/NCT00772707
136764136764Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to ChemotherapyRecruitingNo Results AvailableTesticular CancerDrug: sorafenibhttps://ClinicalTrials.gov/show/NCT00772694
136765136765Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx CarcinomaCompletedNo Results AvailableHead and Neck NeoplasmsDrug: docetaxel and cisplatinhttps://ClinicalTrials.gov/show/NCT00772681
136766136766Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Treating Patients With Stage III or Stage IV Follicular Lymphoma or Marginal Zone LymphomaTerminatedHas ResultsLymphomaDrug: Rituximab|Drug: Bortezomib|Drug: Cyclophosphamide|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00772668
136767136767Zevalin® First Line in Follicular LymphomaActive, not recruitingNo Results AvailableFollicular LymphomaDrug: 90Yttrium-Ibritumomab Tiuxetan (Zevalin®)+Rituximab|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00772655
136768136768Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the WombCompletedNo Results AvailableMalariahttps://ClinicalTrials.gov/show/NCT00772642
136769136769Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy AdultsTerminatedHas ResultsMeningitis|MeningococcemiaBiological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate|Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugatehttps://ClinicalTrials.gov/show/NCT00772629
136770136770Influence of Intraoperative Analgesia on the Postoperative Morphine ConsumptionCompletedNo Results AvailableAnesthesiaDrug: Remifentanil|Drug: Sufentanilhttps://ClinicalTrials.gov/show/NCT00772616

* Görseller ve İçerik tekif hakkına sahip olabilir